It has been suggested that the differences in the expression levels of death (DR4 and DR5) versus decoy (DcR1 and DcR2) receptors can determine the sensitivity of tumor cells to TRAIL-induced apoptosis [6]. Here, TNFRSF10B is linked to neoplasm.